2015/2016. 1.NON-SMALL CELL LUNG CANCER (NSCLC) 1.1 Adenocarcinomas are often found in an outer area of the lung. 1.2 Squamous cell carcinomas are usually.

Slides:



Advertisements
Similar presentations
Analysis of the Epidermal Growth Factor Receptor and K-Ras genes in patients with Non-small Cell Lung Cancer H. Mugalaasi1, J. Davies2, L Medley2, D Talbot2,
Advertisements

Data preprocessing before classification In Kennedy et al.: “Solving data mining problems”
TEMPLATE DESIGN © Distribution of Passenger Mutations in Exponentially Growing Wave 0 Cancer Population Yifei Chen 1 ;
Genetic algorithms applied to multi-class prediction for the analysis of gene expressions data C.H. Ooi & Patrick Tan Presentation by Tim Hamilton.
By Russell Armstrong Supervisor Mrs Wei Ji Diagnosis Analysis of Lung Cancer by Genome Expression Profiles.
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells Colin Reisterer and Nick Swenson S. Maheswaran et al. The New England Journal of Medicine.
Jennie Bell CMGS/ACC Spring meeting 14 th April 2010.
Hazırlayan NEURAL NETWORKS Radial Basis Function Networks II PROF. DR. YUSUF OYSAL.
Data Mining By Andrie Suherman. Agenda Introduction Major Elements Steps/ Processes Tools used for data mining Advantages and Disadvantages.
1 LUNG. 2 Equivalent Terms, Def, Charts, Tables, Illustrations.
Gene expression profiling identifies molecular subtypes of gliomas
ENDA MOLLOY, ELECTRONIC ENG. FINAL PRESENTATION, 31/03/09. Automated Image Analysis Techniques for Screening of Mammography Images.
Classification of multiple cancer types by multicategory support vector machines using gene expression data.
KIF5B-RET fusions in lung adenocarcinoma The lab of technique department xueqiongZhai
Slides last updated: October There are two main types of lung cancer 1 1.Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review,
MATLAB.
Differentials. INFLAMMATORY Pulmonary Tuberculosis History of cough Chest X-ray findings (+) PPD test.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
© 2005 Prentice Hall Inc. / A Pearson Education Company / Upper Saddle River, New Jersey Lung Cancer and Gefitinib  Lung cancer statistics in the.
Evolutionary Algorithms for Finding Optimal Gene Sets in Micro array Prediction. J. M. Deutsch Presented by: Shruti Sharma.
Support Vector Machine Data Mining Olvi L. Mangasarian with Glenn M. Fung, Jude W. Shavlik & Collaborators at ExonHit – Paris Data Mining Institute University.
Bioinformatics and Computational Biology
Short read alignment BNFO 601. Short read alignment Input: –Reads: short DNA sequences (upto a few hundred base pairs (bp)) produced by a sequencing machine.
Supplementary Figure 2: Representative Kaplan-Meier plots of overall survival considering alterations erbB signaling pathway genes and p53 in lung cancer.
FUNCTIONS FUNCTIONS DOMAIN: THE INPUT VALUES FOR A RELATION. USUALLY X INDEPENDENT VARIABLE RANGE: THE OUTPUT VALUES FOR A RELATION. USUALLY.
CAP Cancer BioMarker Reporting Committee Biomarker - Problem, ROI and Scope College of American Pathologists’ Biomarker Reporting Committee Problem 1.Clinicians.
Slides last updated: March There are two main types of lung cancer 1 1.Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review,
YEATS4 Is a Novel Oncogene Amplified in Non– Small Cell Lung Cancer That Regulates the p53 Pathway Speaker:Dai-Wei Hsuan Adviser:Dr. Guor-Mour, Her Data:2015/04/22.
Global Gastric Cancer Market Report: 2016 Edition Phone No.: +1 (214) id:
Anna Buder Institute of Cancer Research Department of Medicine I Medical University of Vienna Liquid Biopsies Analysis of circulating cell-free tumor-DNA.
Main Figures and Tables
EGFR mutation in Austrian patients with NSCLC: a retrospective study
Epidermal growth factor receptor (EGFR) mutations in NSCLC
EGFR exon 20 insertion mutations
Big Data in Genomics, Diagnostics, and Precision Medicine
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations  Adi Gazdar, MD, Linda Robinson, MS, Dwight Oliver, MD,
Fig. 2. High-resolution melting curves for exon 21 of the EGFR gene
Patient Case 1 Patient Case 1: PET/CT Scan.
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Yes, Patient #1 Yes, Patient #3 EGFR sequencing chromatograms
Strategy Description Discovery Validation Application
Volume 9, Issue 6, Pages (June 2006)
Figure 4 Example of a patients with CUP
Detection of EGFR Mutation Status in Lung Adenocarcinoma Specimens with Different Proportions of Tumor Cells Using Two Methods of Differential Sensitivity 
WES detects a limited number of clinically targetable alterations in patients with advanced cancer. WES detects a limited number of clinically targetable.
Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.
Identification and Validation of Long Noncoding RNA Biomarkers in Human Non–Small- Cell Lung Carcinomas  Hui Yu, MD, Qinghua Xu, PhD, Fang Liu, PhD, Xun.
Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non–Small Cell Lung Cancers (NSCLCs) with Liquid Biopsy  Sotirios Lakis,
EGFR Molecular Profiling in Advanced NSCLC: A Prospective Phase II Study in Molecularly/Clinically Selected Patients Pretreated with Chemotherapy  Michele.
Volume 9, Issue 6, Pages (June 2006)
Tetsuya Mitsudomi, MD, Hirohito Tada, MD  Journal of Thoracic Oncology 
Volume 5, Issue 6, Pages e3 (December 2017)
Kelsie L. Thu, BSc, Raj Chari, PhD, William W
Jamie A. Saxon, PhD, Lynette M. Sholl, MD, Pasi A. Jänne, MD, PhD 
Coexistence of Tyrosine Kinase Inhibitor-Sensitizing and Resistant EGFR Mutations in an Untreated Lung Adenocarcinoma Patient and Response to Erlotinib 
Identification of a Novel HIP1-ALK Fusion Variant in Non–Small-Cell Lung Cancer (NSCLC) and Discovery of ALK I1171 (I1171N/S) Mutations in Two ALK-Rearranged.
Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung.
Combination Treatment Using an EGFR Tyrosine Kinase Inhibitor plus Platinum-Based Chemotherapy for a Patient with Transformed Small Cell Carcinoma and.
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Meiotic Microdeletion Breakpoints in the BRCA1 Gene Are Significantly Associated with Symmetric DNA-Sequence Elements  Beatrice Schmucker, Michael Krawczak 
Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non– Small Cell Lung Cancer  Emily Castellanos, MD, Emily Feld, MD, Leora.
Tyrosine kinase inhibitors
CHCHD2 and EGFR protein expression in NSCLC
Prevalence of germline T790M.
Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.
Molecular definitions of lung adenocarcinoma subtypes.
Hyun-Sung Lee, MD, PhD, Cynthia Y. Truong, BS, Bryan M. Burt, MD 
Validation of NAA's cancer specificity in lung cancer.
Advisor: Dr.vahidipour Zahra salimian Shaghayegh jalali Dec 2017
Presentation transcript:

2015/2016

1.NON-SMALL CELL LUNG CANCER (NSCLC) 1.1 Adenocarcinomas are often found in an outer area of the lung. 1.2 Squamous cell carcinomas are usually found in the center of the lung next to an air tube (bronchus). (1.3) Large cell carcinomas can occur in any part of the lung. They tend to grow and spread faster than the other two types.) 2. SMALL CELL LUNG CANCER(SCLC) 2.1 Small cell carcinoma (oat cell cancer). 2.2 Combined small cell carcinoma. 3. CARCINOIDS (COIDS) form a distinct histologic tumor subtype LUNG CANCER Coid

EGFR mutations The tyrosine kinase (TK) domain is a region on the EGFR gene which is prone to mutation in patients with NSLC. The TK domain has 7 exons (exons 18-24), of which exons 8-21 carry somatic mutations in patients with NSCLC.

The data about microdeletions on the EGFR genes was collected from an online database, and the NCBI database nucleotide sequence NG_ was used to build the training data sets. The transformed statistical table is given in Table, and was used for generation of mutated exons’ sequences. For this purpose was developed an algorithm “ approxsimative predictor” in MATLAB, which can generate the required number of mutated exons based on a sample of healthy exons, statistical data on the type of mutation, span of nucleotides that are affected, and the number of patients with this type of mutation shown in Table. Transformed statistical table in MATLAB software package

Approach based on exact identifier Due to the poor results (training, validation, and test errors) of approximative predictor, we developed the model based on generators of “predictive” combinations of all microdeletion mutations on exons 18, 19 and 20 (shown in Figure).  The aim of development of this EGFR mutations identifier was to achieve exact identification of mutated exons 18,19 and 20 in the EGFR gene and thus create the basis for the discovery of new treatments for Non-Small Cell Lung Cancer (NSCLC).  We have developed an integrated software suit using two levels of ensembling: 1. Ensembling of EGFR gene to exons and 2. ensembling of global exon combinations to partial exon combinations.

Ensembling of combinations of the exon 19 to groups of 10 nucleotides  microdeletions in mutated exons.  exon nucleotides can be in two states: deletion or nucleotide is normal.  2 n mutated exons where n is length of exon. PREMISES 1 Instead of generating a 2 lot of combinations for each exon (in real time would take a long time) we generate a 3 combinations of the partial parts of exons, and identified mutations in these parts we integrate in the exon that gives us complete information about mutations. 2 3 EGFR GENE MUTATIONS IDENTIFIER - PREMISES This model consists of three modules:

1. The first module includes preprocessing data (extraction, encoding, and normalization); 2.The second module includes functions for training of radial basis (radbas) neural network ensemble using “predictive” mutations training set. 3. The third module is intended for exploitation in two modes: EGFR GENE MUTATIONS IDENTIFIER - STRUCTURE

DIAGNOSIS PREDICTIVE SYSTEM EGFR GENE MUTATIONS IDENTIFIER On-line mode utilizing sample patients’ data with microdeletion mutations extracted on-line from EGFR mutation database or off- line mode( simulation mode with “predictive” microdeletion mutations from own database). The steps of operation are: masking, exon combinations ensembling, radbas mutations identification and conversion from binary to decimal format, reensembling of partial parts of exons, and counting.

Radial Basis Network Test of radbas identifier with 10 input vectors with 10 binary elements (0= mutation, 1= no mutation), and outputs with decimal identification of positions/number of mutations Identification of mutations;  odd output from radbas network indicates the beginning of a mutation sequence,  and even output indicates the number of mutations from that position